The Application Notebook
Biotage GB Ltd
This application note describes a solid-phase extraction (SPE) protocol for the extraction of a range of mycotoxins from dried chili (pimiento) using ISOLUTE® Myco with LC–MS–MS analysis. The method described achieves high recoveries of relevant mycotoxins from dried chili (pimiento) with %RSDs and LOQs that meet the requirements set in European Union regulations for measurement of these analytes.
Analytes: Aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, ochratoxin A.
Format: ISOLUTE® Myco 60 mg/3 mL columns (Tabless), part number 150-0006-BG.
Sample processing: Grind the sample (50 g) with a burr-grinder or equivalent device. Store ground sample in a sealed container at room temperature until required.
Extraction: Mix the ground sample (5 g) with 80% acetonitrile (aq) (20 mL). Place the sample pre-treatment tube on a shaking table for 30 min. Transfer the extract to a 50 mL centrifuge tube and centrifuge at 4000 g for 10 min.
Dilution: Take the supernatant (2 mL), transfer to a new 50 mL centrifuge tube, and dilute with water (32 mL). Centrifuge diluted extract at 4000 g for a further 10 min.
Use flow rates of 1 mL/min-1 throughout.
Condition: Condition the column with acetonitrile (2 mL).
Equilibration: Equilibrate column with water (2 mL).
Sample loading: Load pre-treated sample (3 mL) onto the column at a maximum flow rate of 1 mL/min-1 (gravity load is recommended).
Interference wash 1: Wash the column with water (2 × 2.5 mL).
Interference wash 2: Wash the column with 10% acetonitrile (aq) (2 × 2.5 mL).
Drying: Dry the column for 30 s at maximum vacuum, –0.5 bar/7 psi.
Elution 1: Elute with 0.1% formic acid in 40% acetonitrile (aq) (2 mL).
Elution 2: Elute with 1.0% ammonia (conc.) in methanol (2 mL).
Post elution: Dry the eluate in a stream of air or nitrogen using a SPE Dry (35 °C, 20 to 40 L/min-1) or TurboVap® LV (15 bar at 35 °C for 40 min). Reconstitute in 0.1 % acetic acid in acetonitrile:methanol:water (1:1:8, v/v/v, 1 mL). Syringe-filter using a 0.2 μm PTFE membrane prior to analysis.
Instrument: Shimadzu Nexera UHPLC (Shimadzu Europe Gmbh)
Column: 50 × 2.1 mm, 2.6-μm dp Kinetex XB-C18 (Phenomenex)
Mobile phase A: 1 mM ammonium acetate, 0.5% acetic acid
Mobile phase B: 1mM ammonium acetate, 0.5% acetic acid in 95% methanol (aq)
Flow rate: 0.45 mL/min-1
Injection: 20 μL
Gradient: Initial 20 % B, hold 1.0 min
linear ramp to 73 % B in 6 min
linear ramp to 100 % B in 0.2 min, hold 2.3 min
linear ramp to initial conditions in 0.2 min
hold 2.3 min, total run time 10.0 min
Column temperature: 40 °C
Sample temperature: 15 °C
Ions were selected in order to achieve maximum sensitivity, and the MS was operated in positive ion polarity mode, using multiple reaction monitoring.
Instrument: AB Sciex Triple Quad 5500 (Warrington, UK)
Source: Turbo-V ESIDesolvation temperature: 500 °C
Curtain gas: 30 psi Spray voltage: +5.0 kV
Gas 1: 60 psi Gas 2: 60 psi Collision gas: 7 psi
Table 1: Analyte recovery (n = 5) and limit of quantitation data for a range of mycotoxins from chili using the ISOLUTE® Myco protocol.
All analytes extracted using the ISOLUTE Myco protocol achieved the limits of quantitation and recovery required by the current European standards for mycotoxin analysis. See Table 1.
Biotage AB
Vimpelgatan 5, Uppsala, Sweden
Tel: +46 18 56 59 00 fax: +46 18 59 19 22
E-mail: info@biotage.com
Website: www.biotage.com
Analyzing Bone Proteins in Forensic Laboratories Using LC−MS/MS
November 4th 2024A recent study compared different workflows for extracting, purifying, and analyzing bone proteins using liquid chromatography with tandem mass spectrometry (LC–MS/MS), including an in-StageTip protocol previously optimized for forensic applications, and two protocols using novel suspension-trap technology (S-Trap) and different lysis solutions. LCGC International discussed this work with Noemi Procopio of the School of Law and Policing and the Research Centre for Field Archaeology and Forensic Taphonomy at the University of Central Lancashire (UK), corresponding author of the paper that resulted from this study.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Profiling Volatile Organic Compounds in Whisky with GC×GC–MS
November 1st 2024Researchers from Austria, Greece, and Italy conducted a study to analyze volatile organic compounds (VOCs) present in Irish and Scotch whiskys using solid-phase microextraction (SPME) Arrow with comprehensive two-dimensional gas chromatography coupled to mass spectrometry (GC×GC–MS) to examine the organoleptic characteristics that influence the taste of spirits.